Factor IX
45% of factor IX coagulant activity
Reference:
Wang L, Zoppe M. Hackeng TM, Griffin JH, Lee KF, Verma IM.: A factor IX-deficient mouse model for hemophilia B gene therapy. Proc Natl Acad Sci USA 1997 Oct 14;94 (21):11563-11566.